Equity | (8) Equity: Treasury Stock On October 2, 2023 our Board of Directors authorized the repurchase of up to $ 10.0 million of our common stock, subject to certain conditions, in the open market, in block purchases, or in privately negotiated transactions. This authorization expired on September 30, 2024 . On September 25, 2024, our Board of Directors approved a program to purchase up to $ 10.0 million of our common stock, subject to certain conditions, in the open market, in block purchases, or in privately negotiated transactions, commencing on October 1, 2024 and executable through September 30, 2025. During the three and nine months ended January 31, 2025, under these authorizations, we repurchased 117,090 and 270,587 shares, respectively, of our common stock for $ 1.2 million and $ 2.6 million, respectively, utilizing cash on hand. Earnings per Share We compute diluted earnings per share by giving effect to all potentially dilutive stock awards that are outstanding. The computation of diluted earnings per share excludes the effect of the potential exercise of stock-based awards when the effect of the potential exercise would be anti-dilutive. All of our outstanding RSUs were included in the computation of diluted earnings per share for the three and nine months ended January 31, 2025. The following table provides a reconciliation of the net income amounts and weighted average number of common and common equivalent shares used to determine basic and diluted earnings per share for the three months ended January 31, 2025 and 2024 (in thousands, except per share data): For the Three Months Ended January 31, 2025 2024 Net Per Share Net Per Share Income Shares Amount Income Shares Amount Basic earnings/(loss) $ 169 12,764 $ 0.01 $ ( 2,910 ) 12,883 $ ( 0.23 ) Effect of dilutive stock awards — 360 — — — — Diluted earnings/(loss) $ 169 13,124 $ 0.01 $ ( 2,910 ) 12,883 $ ( 0.23 ) The following table provides a reconciliation of the net income amounts and weighted average number of common and common equivalent shares used to determine basic and diluted earnings per share for the nine months ended January 31, 2025 and 2024 (in thousands, except per share data): For the Nine Months Ended January 31, 2025 2024 Net Per Share Net Per Share Income Shares Amount Loss Shares Amount Basic earnings/(loss) $ 915 12,830 $ 0.07 $ ( 6,946 ) 13,030 $ ( 0.53 ) Effect of dilutive stock awards — 385 — — — — Diluted earnings/(loss) $ 915 13,215 $ 0.07 $ ( 6,946 ) 13,030 $ ( 0.53 ) Due to the loss from operations for the three and nine months ended January 31, 2024, there are no common shares added to calculate dilutive earnings per share because the effect would be anti-dilutive. Incentive Stock and Employee Stock Purchase Plans We have a stock incentive plan, or 2020 Incentive Compensation Plan, under which we can grant new awards to our employees and directors. We grant RSUs to employees and directors. The awards are made at no cost to the recipient. An RSU represents the right to receive one share of our common stock and does not carry voting or dividend rights. Except in specific circumstances, RSU grants to employees generally vest over a period of three or four years with one-third or one-fourth of the units vesting on each anniversary of the grant date, respectively. We amortize the aggregate fair value of our RSU grants to compensation expense over the vesting period. Awards that do not vest are forfeited. We grant PSUs to our executive officers and certain other employees from time to time. At the time of grant, we calculate the fair value of our PSUs using the Monte-Carlo simulation. We incorporate the following variables into the valuation model: For the Nine Months Ended January 31, 2025 2024 Grant date fair market value American Outdoor Brands, Inc. $ 7.89 $ 8.79 Russell 2000 Index $ 1,980.23 $ 1,769.21 Volatility (a) American Outdoor Brands, Inc. 48.15 % 45.53 % Russell 2000 Index 22.98 % 27.08 % Correlation coefficient (b) 0.37 0.48 Risk-free interest rate (c) 4.73 % 3.81 % Dividend yield (d) 0 % 0 % (a) Expected volatility is calculated based on a peer group over the most recent period that represents the remaining term of the performance period as of the valuation date, or three years . (b) The correlation coefficient utilizes the same historical price data used to develop the volatility assumptions. (c) The risk-free interest rate is based on the yield of a zero-coupon U.S. Treasury bill, commensurate with the three-year performance period. (d) We do not expect to pay dividends in the foreseeable future. The PSUs vest, and the fair value of such PSUs will be recognized, over the corresponding three-year performance period. Our PSUs have a maximum aggregate award equal to 200 % of the target unit amount granted. Generally, the number of PSUs that may be earned depends upon the total stockholder return, or TSR, of our common stock compared with the TSR of the Russell 2000 Index, or the RUT, over the three-year performance period. For PSUs, our stock must outperform the RUT by 5 % in order for the target award to vest. In addition, there is a cap on the number of shares that can be earned under our PSUs, which is equal to six times the grant-date value of each award. During the nine months ended January 31, 2025, we granted an aggregate of 98,412 PSUs to our executive officers. We also granted 278,764 RSUs during the nine months ended January 31, 2025, including 98,412 RSUs to executive officers and 180,352 to non-executive officer employees and directors under our 2020 Incentive Compensation Plan. During the nine months ended January 31, 2025, 23,987 PSUs were cancelled , at target, as a result of the performance condition not being met, and 23,732 RSUs were cancelled as a result of the service condition not being met. In connection with the vesting of RSUs, during the nine months ended January 31, 2025, we delivered common stock to our employees, including our executive officers, and directors with a total market value of $ 2.0 million. During the nine months ended January 31, 2024, we granted an aggregate of 75,894 PSUs to our executive officers. We also granted 318,947 RSUs during the nine months ended January 31, 2024, including 103,118 RSUs to executive officers and 215,829 to non-executive officer employees and directors under our 2020 Incentive Compensation Plan. During the nine months ended January 31, 2024, 79,131 PSUs were cancelled, at target, as a result of the performance condition not being met, and 22,201 RSUs were cancelled as a result of the service condition not being met. In connection with the vesting of RSUs, during the nine months ended January 31, 2024, we delivered common stock to our employees, including our executive officers, and directors with a total market value of $ 1.3 million. We recognized $ 887,000 and $ 1.1 million of stock-based compensation expense for the three months ended January 31, 2025 and 2024, respectively. We recognized $ 2.7 million and $ 3.1 million of stock-based compensation expense for the nine months ended January 31, 2025 and 2024, respectively. We include stock-based compensation expense in the cost of sales, sales and marketing, research and development, and general and administrative expenses. A summary of activity for unvested RSUs and PSUs under our 2020 Incentive Compensation Plan for the nine months ended January 31, 2025 and 2024 is as follows: For the Nine Months Ended January 31, 2025 2024 Weighted Weighted Total # of Average Total # of Average Restricted Grant Date Restricted Grant Date Stock Units Fair Value Stock Units Fair Value RSUs and PSUs outstanding, beginning of period 624,093 $ 11.27 560,579 $ 13.36 Awarded 377,176 8.40 395,384 8.69 Vested ( 226,535 ) 10.59 ( 174,415 ) 11.86 Forfeited ( 46,669 ) 19.70 ( 116,555 ) 12.58 RSUs and PSUs outstanding, end of period 728,065 $ 9.48 664,993 $ 11.16 As of January 31, 2025, there was $ 2.4 million of unrecognized compensation expense related to unvested RSUs and PSUs. We expect to recognize this expense over a weighted average remaining contractual term of 1.3 years. We have an employee stock purchase plan, or ESPP, which authorizes the sale of up to 419,253 shares of our common stock to employees. All options and rights to participate in our ESPP are nontransferable and subject to forfeiture in accordance with our ESPP guidelines. Our current ESPP will be implemented in a series of successive offering periods, each with a maximum duration of 12 months. If the fair market value per share of our common stock on any purchase date is less than the fair market value per share on the start date of a 12-month offering period, then that offering period will automatically terminate and a new 12-month offering period will begin on the next business day. Each offering period will begin on April 1 or October 1, as applicable, immediately following the end of the previous offering period. Payroll deductions will be on an after-tax basis, in an amount of not less than 1 % and not more than 20 % (or such greater percentage as the committee appointed to administer our ESPP may establish from time to time before the first day of an offering period) of a participant’s compensation on each payroll date. The option exercise price per share will equal 85 % of the lower of the fair market value on the first day of the offering period or the fair market value on the exercise date. The maximum number of shares that a participant may purchase during any purchase period is the greater of 2,500 shares, or a total of $ 25,000 in shares, based on the fair market value on the first day of the offering period. Our ESPP will remain in effect until the earliest of (a) the exercise date that participants become entitled to purchase a number of shares greater than the number of reserved shares available for purchase under our ESPP, (b) such date as is determined by our Board of Directors in its discretion, or (c) the tenth anniversary of the effective date. In the event of certain corporate transactions, each option outstanding under our ESPP will be assumed or an equivalent option will be substituted by the successor corporation or a parent or subsidiary of such successor corporation. During the nine months ended January 31, 2025, 38,957 shares were purchased by our employees under our ESPP. We measure the cost of employee services received in exchange for an award of an equity instrument based on the grant-date fair value of the award. We amortize the fair value of the award over the vesting period of the option. Under ESPP, fair value is determined at the beginning of the purchase period and amortized over the term of each exercise period. For the Nine Months Ended January 31, 2025 2024 Risk-free interest rate 3.98 % 5.46 % - 5.53 % Expected term 6 months 6 months - 12 months Expected volatility 40.7 % 43.2 % - 48.9 % Dividend yield 0 % 0 % |